4MF1 | ITK kinase domain in complex with benzothiazole inhibitor 12b (1S,2S)-2-{4-[(DIMETHYLAMINO)METHYL]PHENYL}-N-[6-(1H-PYRAZOL-4-YL)-1,3-BENZOTHIAZOL-2-YL]CYCLOPROPANECARBOXAMIDE | date | 2013-08-27 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Eigenbrot, C., Shia, S. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.11 | ||||||||||||
ligand | 29Y | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Structure-based design and synthesis of potent benzothiazole inhibitors of interleukin-2 inducible T cell kinase (ITK)., Mackinnon CH, Lau K, Burch JD, Chen Y, Dines J, Ding X, Eigenbrot C, Heifetz A, Jaochico A, Johnson A, Kraemer J, Kruger S, Krulle TM, Liimatta M, Ly J, Maghames R, Montalbetti CA, Ortwine DF, Perez-Fuertes Y, Shia S, Stein DB, Trani G, Vaidya DG, Wang X, Bromidge SM, Wu LC, Pei Z, Bioorg Med Chem Lett. 2013 Dec 1;23(23):6331-5. doi: 10.1016/j.bmcl.2013.09.069. , Epub 2013 Oct 1. PMID:24138940 |
Data retrieval |
View 4MF1 in 3D |
Visual 3D analysis of 4MF1 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4MF1 |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |